Could venom-derived therapeutics resolve treatment resistance in refractory EAC?

22

$Could venom-derived therapeutics resolve treatment resistance in refractory EAC?$

Tags:

Previous Article

Whole mouse spatial transcriptomics

Venomics to treat refractory esophageal adenocarcinoma

Related Posts

Mechanisms of whole-genome doubling in cancer evolution

Mechanisms of whole-genome doubling in cancer evolution

34

Protein codes and mobility together shape cellular function and disease

Protein codes and mobility together shape cellular func...

38

Integrating the environmental and genetic architectures of aging and mortality

Integrating the environmental and genetic architectures...

86